Through the layers: how macrophages drive atherosclerosis across the vessel wall

Leah I Susser1,2, Katey J Rayner1,2,3

  • 1Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Insights

Cardiovascular diseases (CVD) are inflammatory conditions, not just due to risk factors like high cholesterol. Macrophages play a key role in the development and resolution of atherosclerosis, the underlying arterial blockage in CVD.

Area of Science:

  • Immunology
  • Cardiology
  • Pathology

Background:

  • Cardiovascular disease (CVD) is the leading cause of global mortality, responsible for nearly half of all non-communicable disease deaths.
  • While traditional risk factors are known, CVDs, particularly coronary artery disease, are increasingly understood as chronic inflammatory conditions.
  • Atherosclerosis, the primary cause of CVD, involves cholesterol accumulation in arterial walls, triggering persistent inflammation.

Purpose of the Study:

  • To review the intricate role of macrophages in the development and progression of atherosclerotic plaques.
  • To discuss emerging concepts that challenge existing paradigms of macrophage function in atherosclerosis.
  • To highlight the evolving understanding of macrophage contributions to cardiovascular disease.

Main Methods:

  • Review of current scientific literature on cardiovascular disease, inflammation, and macrophage biology.
  • Analysis of deep phenotyping methodologies used to study macrophage origins and functions.
  • Synthesis of information on macrophage interactions within the atherosclerotic plaque microenvironment.

Main Results:

  • Macrophages are central players in both the progression and regression of atherosclerotic lesions.
  • Inflammatory cells, particularly macrophages, infiltrate the intimal layer of the vessel wall, driving disease propagation.
  • New research is refining our understanding of macrophage heterogeneity and their specific roles in different stages of plaque development.

Conclusions:

  • Macrophages are critical mediators of the inflammatory processes underlying atherosclerosis.
  • Further research into macrophage biology is essential for developing novel therapeutic strategies for cardiovascular disease.
  • Understanding macrophage dynamics offers new avenues for managing and potentially reversing arterial blockages.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
55.6K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
119
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
55
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
50
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
44
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
78